Indian drugmaker Lupin and a clutch of private equity investors including EQT Partners and TPG Capital are in separate early-stage discussions to acquire UK’s largest nutraceutical company, Vitabiotics, people aware of...
ERIS Lifesciences board approves acquisition of balance 30% stake in Swiss Parenterals
The board of ERIS Lifesciences at its meeting held on 24 November 2025 has approved the acquisition of balance 30% of the total share capital of Swiss Parenterals, a subsidiary of the Company. Further, the board has...
White Oak, Siguler Guff, Creador buy into La Renon Pharma
An investor consortium comprising White Oak Capital Management, US private equity firm Siguler Guff, and Kuala Lumpur-based Creador has acquired about 10% of the pharmaceutical company La Renon Healthcare, said people...
Advent, Warburg join race for stake in Encube Ethicals
Global private equity firms Advent International and Warburg Pincus have joined the race for a stake purchase in contract drug maker Encube Ethicals Pvt. Ltd, three people aware of the development said. Apart from...
Novo Holdings to sell about 8% stake in UK’s ConvaTec, bookrunner says
Novo Holdings, which controls obesity drugmaker Novo Nordisk, will sell 154.5 million shares, or 7.8% of its stake, in British medical products maker ConvaTec Group, a bookrunner for the offering said on Monday. Novo is...
Purdue Pharma Gets Court Nod for Bankruptcy Exit, Sackler Deal
Purdue Pharma LP won court approval to exit bankruptcy, capping six years of legal wrangling over a multibillion-dollar settlement and liability releases for the opioid manufacturer’s Sackler family owners. Judge Sean H...
Pfizer completes up to $10 billion acquisition of Metsera
Pfizer on Thursday closed its up to $10 billion acquisition of Metsera after winning shareholder approval, gaining a foothold in the fast-growing obesity market following a fierce bidding war with Novo Nordisk. The...
Pfizer slashes stake in COVID vaccine partner BioNTech
Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly COVID-19 pandemic. The U.S...
Merck nearing deal for Cidara, FT reports
Merck is closing in on a deal to buy Cidara Therapeutics in a deal valuing the biotechnology company at a premium to its $3.3 billion market capitalization, the Financial Times reported on Thursday. The deal could be...
Shah Capital pushes for Novavax sale, warns of proxy fight
Shah Capital, Novavax’s second-largest shareholder, is pressing the biotech’s board to pursue strategic changes, including a potential sale, and warned it could launch a proxy fight if no progress is made in...
Pfizer to acquire obesity drug startup Metsera in $10 billion deal
Obesity drug developer Metsera said Friday that it had agreed to a deal to be acquired by Pfizer, which had been locked in a bidding war for the company with Novo Nordisk, the Danish maker of weight-loss treatments...
Metsera accepts Pfizer’s $10 billion bid in ongoing M&A battle
Obesity drug developer Metsera said on Friday that it accepted Pfizer’s $10 billion acquisition offer, in what could be the end of a bidding war between the New York-based pharma giant and rival Novo Nordisk that...
